---
schema_version: "secwatch.filing_event.v1"
accession: "0001214659-25-003658"
form_type: "8-K"
ticker: "ALZN"
cik: "0001677077"
company_name: "Alzamend Neuro, Inc."
filed_at: "2025-02-28T23:59:59+00:00"
generated_at: "2026-05-25T23:37:21.603615+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Alzamend Neuro signs $5M financing with Orchid Finance; exchanges Series A pref for Series C with warrants

## Summary
- Exchanges 97.75 Series A shares for 87.99 Series C shares; cancels existing 640K-share warrants.
- Issues up to 500 Series C shares at $9,500 each for total gross proceeds of $5M (net $4.75M after 5% discount).
- Series C carries 15% cumulative quarterly dividend, convertible at formula with $0.10 floor; warrants for 1M shares at $0.92125.
- Tranche closings through Oct 2025; second tranche of 75 shares ($725K) due Apr 29 or 15 days post- registration effectiveness.
- Stockholder approval required for issuances exceeding 19.99% of outstanding; ROFR and participation rights for investor after $712.5K funded.

## SEC filing metadata
- accession: 0001214659-25-003658
- form_type: 8-K
- ticker: ALZN
- cik: 0001677077
- company_name: Alzamend Neuro, Inc.
- filed_at: 2025-02-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1677077/000121465925003658/0001214659-25-003658-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1677077/000121465925003658/z2272508k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001214659-25-003658
- JSON: https://secwatch.observer/filing/0001214659-25-003658.json
- Plain text: https://secwatch.observer/filing/0001214659-25-003658.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.